C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.220
+0.100 (2.43%)
At close: Jun 23, 2026, 4:00 PM EDT
4.282
+0.062 (1.47%)
After-hours: Jun 23, 2026, 6:57 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $466.59 million as of June 23, 2026. Its market cap has increased by 279.83% in one year.
Market Cap
466.59M
Enterprise Value
256.77M
1-Year Change
279.83%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $466.59M, a decrease of -39.62%. That is a compound annual growth rate of -8.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 466.59M | 152.07% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 490.98M |
| Kyverna Therapeutics | 490.62M |
| Assembly Biosciences | 484.33M |
| Artiva Biotherapeutics | 477.14M |
| Prothena Corporation | 467.51M |
| Cabaletta Bio | 463.08M |
| Monopar Therapeutics | 451.97M |
| Contineum Therapeutics | 446.39M |